Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Infinity Pharmaceuti (INFI)

Infinity Pharmaceuti (INFI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Infinity Pharmaceuti 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 USA

P: 617-453-1000 F: 617-453-1001

Description:

Infinity Pharmaceuticals, Inc. is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions.

Key Statistics

Overview:

Market Capitalization, $K 50,829
Shares Outstanding, K 57,434
Annual Sales, $ 3,050 K
Annual Net Income, $ -47,060 K
Last Quarter Sales, $ 430 K
Last Quarter Net Income, $ -10,890 K
60-Month Beta 1.76
% of Insider Shareholders 13.77%
% of Institutional Shareholders 48.60%
Float, K 49,525
% Float 86.23%

Growth:

1-Year Return -30.46%
3-Year Return -19.48%
5-Year Return -90.35%
5-Year Revenue Growth -98.15%
5-Year Earnings Growth -130.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 07/30/20
Earnings Per Share ttm -0.77
EPS Growth vs. Prev Qtr 15.79%
EPS Growth vs. Prev Year 11.11%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-4 on 09/13/06

INFI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -4.67
Price/Earnings to Growth N/A
Return-on-Equity % -537.48%
Return-on-Assets % -78.37%
Profit Margin % -1,542.95
Net Margin % -59.31
Debt/Equity N/A
Price/Sales 15.60
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.04
Interest Coverage -17.40
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar